Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$0.2 - $0.35 $468 - $820
2,344 Added 1172.0%
2,544 $0
Q2 2022

Aug 03, 2022

SELL
$0.18 - $0.29 $75 - $121
-419 Reduced 67.69%
200 $0
Q1 2022

May 02, 2022

SELL
$0.28 - $0.61 $42 - $91
-150 Reduced 19.51%
619 $0
Q4 2021

Feb 23, 2022

BUY
$0.49 - $1.02 $376 - $784
769 New
769 $0
Q2 2021

Aug 12, 2021

SELL
$1.03 - $1.7 $1,477 - $2,437
-1,434 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$1.25 - $2.77 $6,043 - $13,392
-4,835 Reduced 77.13%
1,434 $2,000
Q4 2020

Feb 02, 2021

SELL
$1.18 - $1.98 $1,036 - $1,738
-878 Reduced 12.28%
6,269 $7,000
Q3 2020

Oct 14, 2020

BUY
$1.01 - $1.81 $7,218 - $12,936
7,147 New
7,147 $10,000
Q2 2020

Jul 13, 2020

SELL
$1.03 - $1.69 $32,453 - $53,248
-31,508 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$0.76 - $2.07 $23,946 - $65,221
31,508 New
31,508 $37,000
Q1 2019

Apr 18, 2019

SELL
$2.35 - $3.83 $940 - $1,532
-400 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$2.13 - $4.8 $26,450 - $59,606
-12,418 Reduced 96.88%
400 $0
Q3 2018

Oct 23, 2018

SELL
$2.6 - $4.6 $32,999 - $58,383
-12,692 Reduced 49.75%
12,818 $49,000
Q2 2018

Jul 30, 2018

BUY
$2.13 - $4.2 $39,935 - $78,745
18,749 Added 277.31%
25,510 $86,000
Q1 2018

Apr 26, 2018

BUY
$1.7 - $2.35 $6,970 - $9,635
4,100 Added 154.08%
6,761 $14,000
Q4 2017

Jan 10, 2018

SELL
$1.75 - $5.5 $88,912 - $279,438
-50,807 Reduced 95.02%
2,661 $5,000
Q3 2017

Oct 25, 2017

BUY
$2.9 - $4.6 $155,057 - $245,952
53,468
53,468 $245,000

About ACELRX PHARMACEUTICALS INC


  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.